Epigenetic editing of <i>BRCA1</i> promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Published:2024-05-26 Issue:1 Volume:19 Page:
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

He Wanhong¹,Zhu Haijun¹,Zhang Sufen¹,Shu Guang²,Lei Han²,Wang Maonan²,Yin Gang²,Ni Xiaohua¹,Wu Qihan¹

Affiliation:

1. Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

2. Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China

Funder

Shanghai Municipal Health Commission Funds

Innovation-oriented Science and Technology Grant from NHC Key Lab of Reproduction Regulation

Natural Science Foundation of Shanghai

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15592294.2024.2357518

Reference53 articles.

1. Cancer statistics, 2022

2. Cancer statistics in China, 2015

3. Rethinking ovarian cancer: recommendations for improving outcomes

4. Ovarian cancer statistics, 2018

5. Epithelial ovarian cancer: Evolution of management in the era of precision medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP